– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and ...
– Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform’s capabilities with the integration of Abbott’s FreeStyle ...
FreeStyle Libre sensors are wearable continuous glucose monitoring (CGM) devices that measure glucose and send frequent readings to a compatible reader or smart device. Libre 3 and Libre 3 Plus ...